全部 310 心血管 2,046 高血压 576 心衰 451 心律失常 379 冠心病 310 动脉粥样硬化 281 心肌病 230 血脂 163 心脏瓣膜 66 心血管预防 13

Sex differences in the association of the CRP-TyG index with coronary artery disease and long-term mortality in MASLD.

Frontiers in endocrinology 2026-01-01 浏览 17 冠心病

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) increases cardiovascular risk, but non-invasive tools for risk stratification are limited. The C-reactive protein-triglycer...

DOI 原文

Recipient Left Internal Mammary Artery Salvage for Donor Coronary Artery Disease during Orthotopic Heart Transplantation: A Case Report and Focused Literature Review.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and 2026-01-01 浏览 15 冠心病

Donor coronary artery disease (CAD) can lead to the discard of otherwise suitable hearts, although selected focal lesions may be treated with concomitant revascularization. We report orthotopic heart ...

DOI 原文

Factors associated with adherence to the Mediterranean diet in patients with coronary artery disease: a prospective cohort study.

Revista brasileira de enfermagem 2026-01-01 浏览 17 冠心病

OBJECTIVES: to verify the association between adherence to the Mediterranean diet (MedDiet), sociodemographic, clinical, and biochemical factors, and hospital readmission in patients with coronary art...

DOI 原文

Dynamic Coagulation Function Changes in COVID-19 Survivors With Coronary Artery Disease.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinic 2026-01-01 浏览 19 冠心病

Coronary artery disease (CAD) and Coronavirus disease 2019 (COVID-19) are both associated with a hypercoagulable state, yet the long-term interaction between these prothrombotic conditions remains poo...

DOI 原文

Exploration of SOCS3 and HSPA1A in PANoptosis during acute myocardial infarction and chronic kidney disease.

Frontiers in cellular and infection microbiology 2026-01-01 浏览 19 冠心病

INTRODUCTION: Chronic kidney disease (CKD) is an independent risk factor for acute myocardial infarction (AMI), but the mechanisms underlying their comorbidity remain unclear. As a newly described inf...

DOI 原文

Correlation Between Apolipoprotein B and Severity of Coronary Artery Stenosis in Individuals Aged 45 and Above: A Cross-Sectional Study.

Cardiovascular therapeutics 2026-01-01 浏览 21 冠心病

BACKGROUND: Apolipoprotein B (ApoB) is widely recognized as a biomarker significantly associated with cardiovascular risk. However, the correlation between ApoB and the severity of coronary artery ana...

DOI 原文

A Concomitant Off-Pump Coronary Artery Bypass to TAV-in-TAV in a Patient with a High Risk of Coronary Artery Occlusion.

International heart journal 2026-01-01 浏览 20 冠心病

We report a case of a 90-year-old woman with prior transcatheter aortic valve replacement (TAVR) who presented with symptomatic structural valve deterioration. Imaging revealed a critically short valv...

DOI 原文

High density-lipoprotein regulates liquid-liquid phase separation of heat shock protein β-1 by lncRNA HDRACA to affect vascular inflammation and atherosclerosis.

International journal of biological sciences 2026-01-01 浏览 18 冠心病

High-density lipoprotein (HDL) from healthy subjects (HDLhealthy) has anti-inflammatory effects, whereas HDL from patients with coronary artery disease (HDLCAD) is functionally impaired, which may aff...

DOI 原文

Chain mediation effects of depressive symptoms and nutritional risk between social support and oral frailty in patients with coronary heart disease.

Frontiers in public health 2026-01-01 浏览 18 冠心病

INTRODUCTION: Oral frailty among coronary heart disease (CHD) patients is prevalent and harmful. CHD patients have encountered serious physical and psychological health issues. Social support is a cru...

DOI 原文

Aging-driven metabolic abnormalities remodel intercellular communication through the gut-liver-heart axis and may promote coronary artery disease: the key role of bile acid metabolism.

Frontiers in immunology 2026-01-01 浏览 24 冠心病

Coronary artery disease (CAD) remains the leading cause of cardiovascular mortality worldwide and shows a strong age-dependence that classical risk-factor models do not fully explain. A growing body o...

DOI 原文

Combined diagnostic value of the systemic immune-inflammation index and LDL for coronary microvascular disease: a retrospective cohort study.

Therapeutic advances in cardiovascular disease 2026-01-01 浏览 31 冠心病

BACKGROUND: Coronary microvascular disease (CMVD) is an important contributor to ischemic heart disease. Symptomatic patients without obstructive coronary lesions may still have microvascular ischemia...

DOI 原文

Association between neutrophil percentage-to-albumin ratio and adverse clinical outcomes after successful percutaneous coronary intervention for chronic total occlusion: a cohort study.

Frontiers in immunology 2026-01-01 浏览 20 冠心病

BACKGROUND: Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has improved outcomes, yet residual cardiovascular risk persists. The neutrophil percentage-to-albumin ratio (NPAR), ...

DOI 原文

Association between the C-reactive protein-triglyceride glucose index and coronary collateral circulation in patients with chronic total occlusion: a retrospective study.

PeerJ 2026-01-01 浏览 19 冠心病

OBJECTIVE: To examine the association between the C-reactive protein-triglyceride glucose (CTI) index and coronary collateral circulation (CCC) in patients with chronic total occlusion (CTO), and to a...

DOI 原文

Single-point insulin sensitivity estimator and left main and/or three-vessel disease in patients aged 45 years or older with acute coronary syndrome: findings from the CCC-ACS project.

Frontiers in endocrinology 2026-01-01 浏览 20 冠心病

BACKGROUND: Severe coronary anatomical involvement is clinically important in patients with acute coronary syndrome (ACS), yet evidence on its relationship with insulin sensitivity remains limited. Th...

DOI 原文

HLA-DRB1 and HLA-DQB1 genetic polymorphisms and susceptibility to coronary atherosclerosis in a Northeast Chinese Population: A case-control study.

PloS one 2026-01-01 浏览 29 冠心病

Atherosclerosis is a chronic inflammatory disease with increasing prevalence in Northeast China, where HLA class II molecules play an important immunoregulatory role. However, the contribution of spec...

DOI 原文

Supply of interventional cardiologists and the provision of lower-value Percutaneous Coronary Interventions (PCI).

PloS one 2026-01-01 浏览 32 冠心病

BACKGROUND: Percutaneous coronary interventions (PCI) can be lifesaving for patients with acute coronary syndromes but of lower value for patients with stable coronary artery disease (CAD). Previous s...

DOI 原文

Pragmatic cardiovascular-kidney-metabolic burden categories and 5-year all-cause mortality in Vietnamese outpatients: A retrospective cohort study.

PloS one 2026-01-01 浏览 33 冠心病

BACKGROUND: The American Heart Association introduced cardiovascular-kidney-metabolic (CKM) health as an integrated framework for metabolic, kidney, and cardiovascular risk. However, full AHA CKM stag...

DOI 原文

Association between the C-reactive protein-triglyceride-glucose index and coronary heart disease in metabolic dysfunction-associated steatotic liver disease patients: a cross-sectional study.

Frontiers in endocrinology 2026-01-01 浏览 29 冠心病

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly associated with coronary heart disease (CHD), but convenient and effective biomarkers for identifying CHD risk ...

DOI 原文

Comparison of FINDRISC and the Framingham Model for Predicting CHD Risk: Results from the Kharameh Cohort Study.

Vascular health and risk management 2026-01-01 浏览 30 冠心病

BACKGROUND: Coronary heart disease is a leading cause of death worldwide, making early risk identification essential. This study compares the predictive performance of FINDRISC and the Framingham mode...

DOI 原文

Two-year real-world outcomes of coronary drug-coated balloon therapy: a retrospective comparative study of sirolimus- and paclitaxel-coated devices.

Therapeutic advances in cardiovascular disease 2026-01-01 浏览 32 冠心病

BACKGROUND: Drug-coated balloons (DCBs) represent a "leave-nothing-behind" strategy in percutaneous coronary intervention (PCI), particularly for small vessel disease and in-stent restenosis. However,...

DOI 原文
第 13 / 16 页,共 0 篇
已选择 0 篇文献